Back

The hidden burden of heart failure

2 September 2019 (13:00 - 13:10)
Organised by:
Congress Presentation Part of: Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited) Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Frank Ruschitzka

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
The clinical impact of SGLT2 inhibitor cardiovascular outcomes trials
Doctor M. Bonaca (Aurora, US)
Slides Video
Presentation thumbnail
SGLT2 inhibitors: uncovering the mechanisms of cardiovascular risk reduction
Professor S. Verma (Toronto, CA)
Slides Video
Presentation thumbnail
Lighting the way to the future of heart failure management
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
Questions and answers
Professor F. Ruschitzka (Zurich, CH) Doctor M. Bonaca (Aurora, US) Professor S. Verma (Toronto, CA) Doctor M. Kosiborod (Kansas City, US)
Slides Video

Access the full session

Session thumbnail
Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited)

The Event

Event poster

ESC Congress 2019

2 September 2019 13:00 CET
You may be interested in
thumbnail
ESC Journals
Heart failure: assessment of the global economic burden
30 May 2025
thumbnail
Congress Session
Multidisciplinary approach in heart failure clinic
19 May 2025
thumbnail
Congress Presentation
Functionally limiting symptoms and inability to independently complete activities of daily living increase the burden felt by caregivers to patients with transthyretin amyloid cardiomyopathy
18 May 2025
thumbnail
Congress Presentation
A supportive care program for patients with heart failure: pilot study
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources